Daniel M. Mulvena
Founder bij Commodore Associates, Inc.
Profiel
Founder of Commodore Associates, Inc., Daniel M.
Mulvena presently occupies the position of Chairman at EchoCath, Inc. and Owner at Commodore Associates, Inc.
Mr. Mulvena previously held the position of Chairman of Cambridge Heart, Inc., Chairman, President & Chief Executive Officer at Lithox Systems, Inc., Group Vice President-Cardiology at Boston Scientific Corp.
and President-Cardiosurgery & Implants Division at C.
R.
Bard, Inc. (New Jersey).
He received an undergraduate degree from Vanderbilt University.
Actieve functies van Daniel M. Mulvena
Bedrijven | Functie | Begin |
---|---|---|
EchoCath, Inc.
EchoCath, Inc. Medical SpecialtiesHealth Technology EchoCath, Inc. provides marketing medical devices, which enhance and expand the use of ultrasound technology for medical applications. It develops ultrasound technologies and characterizes blood flow and enables ultrasound imaging and identifying devices during interventional procedures such as needle biopsies and catheterizations. The company's technologies include a proprietary transcutaneous, epivascular and catheter based sensor and electronics system which provide data on the blood flow through internal vessels. EchoCath was founded on February 14, 1990 and is headquartered in Princeton, NJ. | Chairman | 15-03-2010 |
Commodore Associates, Inc. | Founder | 11-12-2009 |
Eerdere bekende functies van Daniel M. Mulvena
Bedrijven | Functie | Einde |
---|---|---|
THORATEC CORPORATION | Director/Board Member | 21-05-2014 |
ZOLL Medical Corp.
ZOLL Medical Corp. Medical SpecialtiesHealth Technology ZOLL Medical Corp. develops and markets medical devices and related software solutions for emergency care. It provides products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management. The firm provides technologies which help fire professionals, clinicians, and rescuers in providing critical care and resuscitation treatment. It also designs software that automates data documentation and management for both clinical and non-clinical information. The company was founded by William Bright, Rolf S. Stutz, Paul M. Zoll, Leigh Stein, and Thomas M. Claflin in 1980 and is headquartered in Chelmsford, MA. | Director/Board Member | 10-02-2011 |
YUBO INTERNATIONAL BIOTECH LIMITED | Director/Board Member | 01-05-2004 |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01-05-1995 |
Lithox Systems, Inc. | Chairman | - |
Opleiding van Daniel M. Mulvena
Vanderbilt University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Distribution Services |
YUBO INTERNATIONAL BIOTECH LIMITED | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
C. R. Bard, Inc. (New Jersey)
C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
ZOLL Medical Corp.
ZOLL Medical Corp. Medical SpecialtiesHealth Technology ZOLL Medical Corp. develops and markets medical devices and related software solutions for emergency care. It provides products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management. The firm provides technologies which help fire professionals, clinicians, and rescuers in providing critical care and resuscitation treatment. It also designs software that automates data documentation and management for both clinical and non-clinical information. The company was founded by William Bright, Rolf S. Stutz, Paul M. Zoll, Leigh Stein, and Thomas M. Claflin in 1980 and is headquartered in Chelmsford, MA. | Health Technology |
Thoratec Corp.
Thoratec Corp. Medical SpecialtiesHealth Technology Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag Acute Circulatory System, HeartMate II, PVAD, IVAD and for pediatric patients PediMag/PediVAS Acute Circulatory System. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures mechanical circulatory products to support the cardiovascular systems of humans and to provide product-related services. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA. | Health Technology |
Cambridge Heart, Inc.
Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Cambridge Heart, Inc. engages in the development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company was founded by Jeffrey M. Arnold and Jordan S. Davis on January 16, 1990 and is headquartered in Tewksbury, MA. | Health Technology |
EchoCath, Inc.
EchoCath, Inc. Medical SpecialtiesHealth Technology EchoCath, Inc. provides marketing medical devices, which enhance and expand the use of ultrasound technology for medical applications. It develops ultrasound technologies and characterizes blood flow and enables ultrasound imaging and identifying devices during interventional procedures such as needle biopsies and catheterizations. The company's technologies include a proprietary transcutaneous, epivascular and catheter based sensor and electronics system which provide data on the blood flow through internal vessels. EchoCath was founded on February 14, 1990 and is headquartered in Princeton, NJ. | Health Technology |
Commodore Associates, Inc. | |
Lithox Systems, Inc. |